We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Globus Medical (GMED) Progresses With ExcelsiusGPS in DBS
Read MoreHide Full Article
Globus Medical, Inc. (GMED - Free Report) recently made a new development in the field of Deep Brain Stimulation (DBS). The company performed the first surgery with the ExcelsiusGPS Cranial Solutions for robot-assisted navigated DBS.
Cranial Solutions is the latest version of the ExcelsiusGPS platform, transforming it into a 2-in-1 application system. This is currently commercially available in the United States.
This latest generation system combines streamlined MRI preoperative planning with fully integrated robotic trajectory alignment. It serves a broad spectrum of cranial stereotactic procedures including SEEG, DBS, biopsies, and shunts.
According to Globus Medical, with the only Fluoroscopy-to-CT registration modality on the market, ExcelsiusGPS Cranial Solutions helps surgeons to efficiently register the bony anatomy.
Its actively navigated end effector automatically and precisely aligns to planned trajectories without the need for a stereotactic arc. This platform can easily adapt to a surgeon’s workflow and preferred instruments.
The recent milestone for the ExcelsiusGPS platform is likely to highlight Globus Medical’s robotics business.
Industry Prospects
Per a report published in Globe Newswire, the global surgical robotics and navigation market is expected to see a CAGR of 21.7% by 2027. Factors driving market growth include the development of several user-friendly and technologically developed robotic platforms, an increase in automation in the healthcare sector, growing demand for minimally-invasive treatments, and higher adoption of advanced technology in developed and developing economies.
Given the substantial market prospects, the recent completion of 20,000 spine procedures with Globus Medical’s ExcelsiusGPS platform comes at an opportune time.
Recent Developments Using ExcelsiusGPS
According to Globus Medical, the clinical superiority of ExcelsiusGPS continues to be recognized by surgeons. In July, the ExcelsiusGPS Robotic Navigation system was utilized to perform over 20,000 spine procedures. The number of procedures that incorporated the ExcelsiusGPS platform touched an all-time high, reflecting an acceleration in adoption in the United States.
Image Source: Zacks Investment Research
In April 2021, the company launched CREO ONE, the market’s first robotic screw designed for spine surgery with ExcelsiusGPS. The CREO ONE simplifies pedicle preparation while maintaining navigational accuracy and increasing pullout strength by 86% compared to traditional pedicle screws tapped to size.
Share Price Performance
The stock has outperformed its industry over the past year. It has rallied 64.5% compared with the industry’s growth of 2.1%.
Zacks Rank and Key Picks
Currently, Globus Medical carries a Zacks Rank #3 (Hold).
Image: Bigstock
Globus Medical (GMED) Progresses With ExcelsiusGPS in DBS
Globus Medical, Inc. (GMED - Free Report) recently made a new development in the field of Deep Brain Stimulation (DBS). The company performed the first surgery with the ExcelsiusGPS Cranial Solutions for robot-assisted navigated DBS.
Cranial Solutions is the latest version of the ExcelsiusGPS platform, transforming it into a 2-in-1 application system. This is currently commercially available in the United States.
This latest generation system combines streamlined MRI preoperative planning with fully integrated robotic trajectory alignment. It serves a broad spectrum of cranial stereotactic procedures including SEEG, DBS, biopsies, and shunts.
According to Globus Medical, with the only Fluoroscopy-to-CT registration modality on the market, ExcelsiusGPS Cranial Solutions helps surgeons to efficiently register the bony anatomy.
Its actively navigated end effector automatically and precisely aligns to planned trajectories without the need for a stereotactic arc. This platform can easily adapt to a surgeon’s workflow and preferred instruments.
The recent milestone for the ExcelsiusGPS platform is likely to highlight Globus Medical’s robotics business.
Industry Prospects
Per a report published in Globe Newswire, the global surgical robotics and navigation market is expected to see a CAGR of 21.7% by 2027. Factors driving market growth include the development of several user-friendly and technologically developed robotic platforms, an increase in automation in the healthcare sector, growing demand for minimally-invasive treatments, and higher adoption of advanced technology in developed and developing economies.
Given the substantial market prospects, the recent completion of 20,000 spine procedures with Globus Medical’s ExcelsiusGPS platform comes at an opportune time.
Recent Developments Using ExcelsiusGPS
According to Globus Medical, the clinical superiority of ExcelsiusGPS continues to be recognized by surgeons. In July, the ExcelsiusGPS Robotic Navigation system was utilized to perform over 20,000 spine procedures. The number of procedures that incorporated the ExcelsiusGPS platform touched an all-time high, reflecting an acceleration in adoption in the United States.
In April 2021, the company launched CREO ONE, the market’s first robotic screw designed for spine surgery with ExcelsiusGPS. The CREO ONE simplifies pedicle preparation while maintaining navigational accuracy and increasing pullout strength by 86% compared to traditional pedicle screws tapped to size.
Share Price Performance
The stock has outperformed its industry over the past year. It has rallied 64.5% compared with the industry’s growth of 2.1%.
Zacks Rank and Key Picks
Currently, Globus Medical carries a Zacks Rank #3 (Hold).
A few better-ranked stocks from the Medical-Instruments industry include Semler Scientific Inc. , Alcon Inc. (ALC - Free Report) , and IDEXX Laboratories, Inc. (IDXX - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Semler Scientific has a long-term earnings growth rate of 25%.
Alcon has a long-term earnings growth rate of 17.7%.
IDEXX has a long-term earnings growth rate of 19.9%.